Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

24 mars 2026 07h00 HE | Source: Tandym Group

Tandym Group Acquires InteliNotion, Expanding AI-Driven Structured Content Capabilities for Life Sciences and Regulated Industries

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Tandym Group, a leader in specialized solutions for the healthcare, life sciences, technology, and professional services industries, today announced its...
23 mars 2026 11h46 HE | Source: ProductLife Group (PLG)

Dr. James Burt Joins ProductLife Group as CEO

ProductLife Group appoints Dr. James Burt as CEO, strengthening global growth and capabilities across regulatory, clinical, quality and digital services.
23 mars 2026 10h05 HE | Source: AdipoPharma

AdipoPharma Enters Clinic with First-in-Class Therapy Targeting Type 2 diabetes with the potential to maintain muscle mass

PITTSBURGH, March 23, 2026 (GLOBE NEWSWIRE) -- As GLP-1 therapies reshape obesity care, one biotech company is betting that the root cause of Type 2 diabetes isn’t only excessive weight but a...
16 mars 2026 08h20 HE | Source: SciSparc Ltd

SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy

TEL AVIV, Israel, March 16, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage...
12 mars 2026 07h55 HE | Source: SciSparc Ltd

SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease

TEL AVIV, Israel, March 12, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage...
11 mars 2026 11h10 HE | Source: Io Therapeutics, Inc.

Io Therapeutics, Inc. announces publication of studies on the company’s RXR agonist compound IRX4204 for breast cancer prevention

Io Therapeutics reports publication of studies on its RXR agonist compound for prevention of Triple Negative Breast Cancer.
10 mars 2026 14h00 HE | Source: Custom Market Insights

[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

Global Pharmaceutical Microbiology QC Testing Market grows as demand rises for sterility, bioburden, and endotoxin testing in pharmaceutical and biologics.
10 mars 2026 08h03 HE | Source: API Innovation Center

API Innovation Center Highlights Fragility in U.S. Drug Supply Chain in New White Paper

ST. LOUIS, March 10, 2026 (GLOBE NEWSWIRE) -- The API Innovation Center (APIIC), a nonprofit dedicated to strengthening national health security through U.S. generic pharmaceutical manufacturing and...
10 mars 2026 02h30 HE | Source: Custom Market Insights

[Latest] Global Viral Vaccine Cell Culture Media Market Size/Share Worth USD 3.5 Billion by 2035 at a 6.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, March 10, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Viral Vaccine Cell Culture Media Market Size, Trends and Insights By Cell...
02 mars 2026 06h30 HE | Source: Alaunos Therapeutics, Inc.

Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders

Alaunos’ ALN1003 shows dose dependent weight loss, better body composition, reduced liver weight, and improved liver biomarkers in preclinical studies.

Page suivante